---
figid: PMC5880129__zbc0141878860002
figlink: /pmc/articles/PMC5880129/figure/F2/
number: F2
caption: Copper-signaling pathways and molecular targets in mammalian biology. Left
  (Cancer Cell), stimulation of growth factor receptors (GFRs) or mutations in proto-oncogene
  protein B-Raf (BRAF) cause activation of the MAPK pathway, leading to phosphorylation
  of mitogen-activated protein kinase kinase (MAP2K1/2 or MEK1/2). MEK1/2 activation
  requires direct binding of cellular copper, which is supplied through the copper
  importer CTR1. Fully activated MEK1/2 phosphorylates MAPK or ERK, leading to tumor
  growth. Right (Adipocyte), activation of the β-adrenergic receptor (β-AR) causes
  recruitment of a G-protein (Gs) and activation of adenylyl cyclase (AC). Adenylyl
  cyclase converts adenosine triphosphate (ATP) to cyclic-adenosine monophosphate
  (cAMP), which activates downstream pathways leading to lipolysis. The pathway is
  shut down when cAMP is hydrolyzed by phosphodiesterase 3B (PDE). However, direct
  binding of copper to phosphodiesterase inhibits cAMP hydrolysis and maintains activation
  of the lipolysis pathway.
pmcid: PMC5880129
papertitle: Copper signaling in the brain and beyond.
reftext: Cheri M. Ackerman, et al. J Biol Chem. 2018 Mar 30;293(13):4628-4635.
pmc_ranked_result_index: '28904'
pathway_score: 0.976512
filename: zbc0141878860002.jpg
figtitle: Copper-signaling pathways and molecular targets in mammalian biology
year: '2018'
organisms: Homo sapiens
ndex: d5ded442-dea2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5880129__zbc0141878860002.html
  '@type': Dataset
  description: Copper-signaling pathways and molecular targets in mammalian biology.
    Left (Cancer Cell), stimulation of growth factor receptors (GFRs) or mutations
    in proto-oncogene protein B-Raf (BRAF) cause activation of the MAPK pathway, leading
    to phosphorylation of mitogen-activated protein kinase kinase (MAP2K1/2 or MEK1/2).
    MEK1/2 activation requires direct binding of cellular copper, which is supplied
    through the copper importer CTR1. Fully activated MEK1/2 phosphorylates MAPK or
    ERK, leading to tumor growth. Right (Adipocyte), activation of the β-adrenergic
    receptor (β-AR) causes recruitment of a G-protein (Gs) and activation of adenylyl
    cyclase (AC). Adenylyl cyclase converts adenosine triphosphate (ATP) to cyclic-adenosine
    monophosphate (cAMP), which activates downstream pathways leading to lipolysis.
    The pathway is shut down when cAMP is hydrolyzed by phosphodiesterase 3B (PDE).
    However, direct binding of copper to phosphodiesterase inhibits cAMP hydrolysis
    and maintains activation of the lipolysis pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDE1A
  - PDE6B
  - PDE8B
  - BRAF
  - PDE7B
  - PDE11A
  - PDE7A
  - PDE8A
  - PDE9A
  - PDE1B
  - PDE2A
  - PDE3A
  - SLC31A1
  - PDE6A
  - PDE6C
  - MAPK3
  - PDE10A
  - MAP2K1
  - PDE1C
  - PDE4B
  - PDE3B
  - RAPGEF5
  - MAPK1
  - PDE4D
  - PDE4C
  - PDE4A
genes:
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: CTR1
  symbol: CTR1
  source: hgnc_alias_symbol
  hgnc_symbol: SLC31A1
  entrez: '1317'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: MEK1/2)
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: GFR
  symbol: GFR
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF5
  entrez: '9771'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
chemicals: []
diseases: []
figid_alias: PMC5880129__F2
redirect_from: /figures/PMC5880129__F2
figtype: Figure
---
